Viewpoint Capital Management LLC Lowers Holdings in The Clorox Company $CLX

Viewpoint Capital Management LLC trimmed its position in The Clorox Company (NYSE:CLX) by 3.5% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 9,636 shares of the company’s stock after selling 349 shares during the period. Viewpoint Capital Management LLC’s holdings in Clorox were worth $1,157,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in CLX. Belpointe Asset Management LLC raised its position in shares of Clorox by 10.5% in the second quarter. Belpointe Asset Management LLC now owns 3,516 shares of the company’s stock worth $422,000 after buying an additional 335 shares in the last quarter. Grimes & Company Inc. increased its stake in Clorox by 16.2% in the 2nd quarter. Grimes & Company Inc. now owns 68,879 shares of the company’s stock worth $8,270,000 after acquiring an additional 9,615 shares during the last quarter. Measured Risk Portfolios Inc. raised its holdings in shares of Clorox by 6.7% in the 2nd quarter. Measured Risk Portfolios Inc. now owns 12,388 shares of the company’s stock valued at $1,487,000 after acquiring an additional 778 shares in the last quarter. Simplicity Wealth LLC raised its holdings in shares of Clorox by 157.3% in the 2nd quarter. Simplicity Wealth LLC now owns 18,316 shares of the company’s stock valued at $2,199,000 after acquiring an additional 11,198 shares in the last quarter. Finally, Brown Miller Wealth Management LLC boosted its position in shares of Clorox by 18.9% during the 2nd quarter. Brown Miller Wealth Management LLC now owns 3,225 shares of the company’s stock valued at $387,000 after acquiring an additional 513 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently weighed in on CLX. Citigroup restated a “neutral” rating and issued a $135.00 price objective (down from $140.00) on shares of Clorox in a research report on Tuesday, July 15th. Jefferies Financial Group decreased their price target on shares of Clorox from $167.00 to $145.00 and set a “buy” rating on the stock in a report on Thursday, June 26th. Barclays dropped their price objective on shares of Clorox from $118.00 to $112.00 and set an “underweight” rating for the company in a report on Tuesday, September 30th. JPMorgan Chase & Co. increased their target price on Clorox from $133.00 to $135.00 and gave the company a “neutral” rating in a research note on Monday, September 8th. Finally, The Goldman Sachs Group lowered their price target on Clorox from $115.00 to $110.00 and set a “sell” rating on the stock in a research report on Wednesday, October 1st. One equities research analyst has rated the stock with a Buy rating, ten have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, Clorox presently has an average rating of “Reduce” and a consensus price target of $134.08.

Insider Transactions at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This trade represents a 21.72% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.57% of the stock is currently owned by insiders.

Clorox Price Performance

CLX stock opened at $118.74 on Tuesday. The firm has a market cap of $14.52 billion, a P/E ratio of 18.21, a P/E/G ratio of 1.00 and a beta of 0.52. The firm’s fifty day moving average is $122.64 and its 200 day moving average is $129.23. The Clorox Company has a 52 week low of $116.53 and a 52 week high of $171.37. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.94 billion. During the same period in the previous year, the firm posted $1.82 earnings per share. The firm’s revenue for the quarter was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Research analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be issued a dividend of $1.24 per share. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a yield of 4.2%. Clorox’s dividend payout ratio is currently 76.07%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.